Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
43
pubmed:dateCreated
1998-11-17
pubmed:abstractText
A novel C to A mutation in the sterol 27-hydroxylase gene (CYP27) was identified by sequencing amplified CYP27 gene products from a patient with cerebrotendinous xanthomatosis (CTX). The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser (CGT 362Arg to AGT 362Ser), and was responsible for deficiency in the sterol 27-hydroxylase activity, as confirmed by expression of mutant cDNA into COS-1 cells. Quantitative analysis showed that the expression of CYP27 gene mRNA in the patient represented 52.5% of the normal level. As the mutation occurred at the penultimate nucleotide of exon 6 (-2 position of exon 6-intron 6 splice site) of the gene, we hypothesized that the mutation may partially affect the normal splicing efficiency in exon 6 and cause alternative splicing elsewhere, which resulted in decreased transcript in the patient. Transfection of constructed minigenes, with or without the mutation, into COS-1 cells confirmed that the mutant minigene was responsible for a mRNA species alternatively spliced at an activated cryptic 5' splice site 88 bp upstream from the 3' end of exon 6. Our data suggest that the C to A mutation at the penultimate nucleotide of exon 6 of the CYP27 gene not only causes the deficiency in the sterol 27-hydroxylase activity, but also partially leads to alternative pre-mRNA splicing of the gene. To our knowledge, this is the first report regarding effects on pre-mRNA splicing of a mutation at the -2 position of a 5' splice site.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
37
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15050-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9790667-Alternative Splicing, pubmed-meshheading:9790667-Amino Acid Substitution, pubmed-meshheading:9790667-Animals, pubmed-meshheading:9790667-Arginine, pubmed-meshheading:9790667-COS Cells, pubmed-meshheading:9790667-Cytochrome P-450 CYP27A1, pubmed-meshheading:9790667-Cytochrome P-450 Enzyme System, pubmed-meshheading:9790667-DNA, Complementary, pubmed-meshheading:9790667-Enzyme Activation, pubmed-meshheading:9790667-Humans, pubmed-meshheading:9790667-Male, pubmed-meshheading:9790667-Middle Aged, pubmed-meshheading:9790667-Point Mutation, pubmed-meshheading:9790667-RNA Precursors, pubmed-meshheading:9790667-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:9790667-Serine, pubmed-meshheading:9790667-Steroid Hydroxylases, pubmed-meshheading:9790667-Transcription, Genetic, pubmed-meshheading:9790667-Transfection, pubmed-meshheading:9790667-Xanthomatosis, Cerebrotendinous
pubmed:year
1998
pubmed:articleTitle
A novel Arg362Ser mutation in the sterol 27-hydroxylase gene (CYP27): its effects on pre-mRNA splicing and enzyme activity.
pubmed:affiliation
Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, The University of Tokyo, Japan.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't